Alnylam Pharmaceuticals Says It's Stopping Work on a Treatment for a Rare Eye Disease ... - Latest Tweet by Bloomberg

Alnylam Pharmaceuticals says it’s stopping work on a treatment for a rare eye disease because of a new US drug-pricing law with the potential to limit how much it could charge for the medication https://t.co/XGEEJwsjLD— Bloomberg (@business) October 27, 2022

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)